Clinical Trials on Eosinophilic Bronchitis in Denmark

Total 23 results

Bispebjerg Hospital
Lund University; University of Copenhagen; Herlev and Gentofte Hospital

Recruiting

Anti-viral Effects of Azithromycin in Patients With Asthma and COPD (AZIMUNE)

Immune System Diseases | Lung Diseases | Bronchial Diseases | Lung Diseases, Obstructive | Asthma | COPD | Exacerbation Copd | Asthma; Eosinophilic

Denmark
Rigshospitalet, Denmark

Recruiting

A Randomized, Real-world Head-to-head Study of Dupilumab Versus Mepolizumab in Danish CRSwNP Patients (TORNADO)

Eosinophilia | Chronic Rhinosinusitis With Nasal Polyps | Asthma; Eosinophilic

Denmark
Liita Care ApS

Suspended

Muco-ciliary Cleansing of Lungs in COPD With and Without a Salt Particle Inhaler

COPD | Copd Bronchitis

Denmark
AstraZeneca
Amgen

Recruiting

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis (CROSSING)

Eosinophilic Esophagitis

United States, Czechia, Spain, China, Australia, Italy, Belgium, Finland, Norway, Japan, Brazil, Germany, Greece, Canada, Netherlands, Sweden, Israel, Denmark, Austria, Slovakia, New Zealand, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma

Eosinophilic Asthma

United States, Australia, Belgium, Chile, Colombia, Czechia, Denmark, Hungary, Israel, Malaysia, New Zealand, Philippines, Poland, Russian Federation, South Africa, Sweden, Thailand
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma

Eosinophilic Asthma

United States, Australia, Belgium, Chile, Colombia, Denmark, Hungary, Israel, Malaysia, New Zealand, Philippines, Poland, Russian Federation, South Africa, Sweden, Thailand, Argentina, Brazil, Canada, France, Mexico, Netherlands, Ge... and more
University of Aarhus
Aarhus University Hospital

Completed

Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease

Emphysema | Chronic Obstructive Pulmonary Disease (COPD) | Chronic Bronchitis | Chronic Obstructive Lung Disease | Chronic Obstructive Airway Disease

Denmark
Asger Sverrild
AstraZeneca; University Hospitals, Leicester; University Hospital, Antwerp

Recruiting

Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD (UPSTREAM-COPD)

COPD | COPD Exacerbation | Immune System Disorder | Airway Disease | COPD Bronchitis

United Kingdom, Belgium, Denmark
Hospital of South West Jutland

Completed

Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.

Respiratory Syncytial Virus Bronchiolitis

Denmark
Aarhus University Hospital Skejby

Completed

Procalcitonin as a Marker of Bacterial Pneumonia

Pneumonia | Bronchitis | COPD

Denmark
University of Aarhus
InCor Heart Institute; Hospital das Clínicas de Ribeirão Preto

Completed

Lymphatic Morphology of Fontan Patients

Congenital Heart Disease | Univentricular Heart | Protein-Losing Enteropathies | Plastic Bronchitis | Lymphatic Abnormality

Denmark
Chronic Obstructive Pulmonary Disease Trial Network...

Completed

Corticosteroid Reduction in COPD (Cortico-cop)

Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPD | Glucocorticoids | Blood Eosinophil Count

Denmark
AstraZeneca

Completed

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis (FRONTIER-4)

Chronic Obstructive Pulmonary Disease (COPD) | Chronic Bronchitis

United States, Canada, Denmark, Spain, United Kingdom, Taiwan, New Zealand, Australia, Germany, Israel, South Africa, Czechia, Hungary, Poland, Netherlands
Rigshospitalet, Denmark

Completed

European Trial of Pirfenidone in BOS, A European Multi-center Study (EPOS)

Disorder Related to Lung Transplantation | CLAD, Bronchiolitis Obliterans

United Kingdom, Belgium, Denmark, Germany, Netherlands, Norway, Sweden
Oslo University Hospital
Vestre Viken Hospital Trust; University of Oslo; Haukeland University Hospital; Sorlandet Hospital HF and other collaborators

Unknown

Bronchiolitis All-study, SE-Norway

Bronchiolitis

Norway
AstraZeneca

Recruiting

A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES) (NATRON)

Hypereosinophilic Syndrome

United States, Spain, Poland, Belgium, India, Japan, Italy, France, Germany, Austria, Denmark, Israel, Netherlands, Switzerland, Korea, Republic of, United Kingdom
GlaxoSmithKline

Recruiting

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial (DESTINY)

Hypereosinophilic Syndrome

United States, Italy, Japan, Spain, Argentina, Belgium, China, Korea, Republic of, Czechia, Germany, Israel, Denmark, Poland, Brazil, Greece, Turkey, Mexico, Australia, Hong Kong, Romania, United Kingdom
Zambon SpA

Enrolling by invitation

Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) (BOSTON-3)

Bronchiolitis Obliterans | Bronchiolitis Obliterans Syndrome | Obliterative Bronchiolitis

France, United States, Spain, Israel, Belgium, Denmark, Germany, United Kingdom, Austria
Sanofi

Recruiting

A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. (ROCKnrol-1)

Chronic Graft Versus Host Disease

Australia, Argentina, Belgium, Spain, Sweden, Czechia, United Kingdom, United States, Italy, Germany, Canada, Israel, Denmark, Brazil
Zambon SpA

Active, not recruiting

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2) (BOSTON-2)

Bronchiolitis Obliterans | Lung Transplant Rejection | Lung Transplant; Complications | Lung Transplant Failure and Rejection | Chronic Rejection of Lung Transplant | Chronic Lung Allograft Dysfunction

France, United States, Spain, Israel, Belgium, Denmark, Germany, United Kingdom, Austria
Incyte Corporation

Terminated

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Chronic Graft-versus-host Disease

United States, Spain, France, Canada, Israel, United Kingdom, Germany, Italy, Denmark, Sweden, Finland, Belgium, Poland, Greece, Austria, Switzerland
University of British Columbia
University of Oxford; BC Childrens Hospital Research Institute

Recruiting

Pediatric Vasculitis Initiative (PedVas)

Microscopic Polyangiitis | Polyarteritis Nodosa | Eosinophilic Granulomatosis With Polyangiitis | Takayasu Arteritis | Wegeners Granulomatosis (Granulomatosis With Polyangiitis) | Primary CNS Vasculitis | Unclassified Vasculitis

Canada, United States, Thailand, United Kingdom, Germany, India, Denmark
Novartis Pharmaceuticals

Completed

A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Hypereosinophilic Syndrome | Chronic Myelogenous Leukemia | Systemic Mastocytosis | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)

United States, Poland, Italy, Belgium, Canada, France, Australia, Netherlands, Sweden, Switzerland, United Kingdom, Spain, Korea, Republic of, Austria, Germany, Denmark, Finland, Singapore, Taiwan, Hong Kong, New Zealand, Norway

Clinical Trials on Eosinophilic Bronchitis in Denmark

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations